Search Results - "MURASE, Saori"
-
1
Mechanism-based Inhibition Profiles of Erythromycin and Clarithromycin with Cytochrome P450 3A4 Genetic Variants
Published in Drug metabolism and pharmacokinetics (2013)“…Inhibition of cytochrome P450 (CYP) 3A4 is the major cause of drug-drug interactions (DDI). We have previously reported that the genetic variation of CYP3A4…”
Get full text
Journal Article -
2
Comparison of the Inhibitory Profiles of Itraconazole and Cimetidine in Cytochrome P450 3A4 Genetic Variants
Published in Drug metabolism and disposition (01-04-2011)“…CYP3A4, an important drug-metabolizing enzyme, is known to have genetic variants. We have previously reported that CYP3A4 variants such as CYP3A4.2, 7, 16, and…”
Get full text
Journal Article -
3
Mechanism-based Inhibition Profiles of Erythromycin and Clarithromycin with Cytochrome P450 3A4 Genetic Variants
Published in DRUG METABOLISM AND PHARMACOKINETICS (25-10-2013)“…[Summary]: Inhibition of cytochrome P450 (CYP) 3A4 is the major cause of drug-drug interactions (DDI). We have previously reported that the genetic variation…”
Get full text
Journal Article -
4
Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits
Published in International journal of medical sciences (06-08-2009)“…Purpose: Phlebitis caused by intravenous infusion of antineoplastic agents is one of the critical problems when anticancer therapy is prolonged. We have…”
Get full text
Journal Article -
5
Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits
Published in International journal of medical sciences (22-07-2008)“…In order to identify methods for preventing phlebitis caused by intravenous administration of vinorelbine (VNR), we established a procedure for estimating the…”
Get full text
Journal Article -
6
Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits
Published in International journal of medical sciences (06-08-2009)“…Phlebitis caused by intravenous infusion of antineoplastic agents is one of the critical problems when anticancer therapy is prolonged. We have already…”
Get full text
Journal Article